These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26325271)

  • 1. Folliculogenesis Is Not Fully Inhibited during GnRH Analogues Treatment in Mice Challenging Their Efficiency to Preserve the Ovarian Reserve during Chemotherapy in This Model.
    Horicks F; Van Den Steen G; Houben S; Englert Y; Demeestere I
    PLoS One; 2015; 10(9):e0137164. PubMed ID: 26325271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both in vivo FSH depletion and follicular exposure to Gonadotrophin-releasing hormone analogues in vitro are not effective to prevent follicular depletion during chemotherapy in mice.
    Horicks F; Van Den Steen G; Gervy C; Clarke HJ; Demeestere I
    Mol Hum Reprod; 2018 Apr; 24(4):221-232. PubMed ID: 29438534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of cyclophosphamide-induced ovarian damage by concomitant administration of GnRHa in mice: a dose-dependent relationship?
    Yüce MA; Balkanli Kaplan P; Gücer F; Doğanay L; Altaner S; Canda T; Yardim T
    Eur J Gynaecol Oncol; 2004; 25(5):628-31. PubMed ID: 15493183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice.
    Meirow D; Assad G; Dor J; Rabinovici J
    Hum Reprod; 2004 Jun; 19(6):1294-9. PubMed ID: 15117898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
    Bildik G; Akin N; Senbabaoglu F; Sahin GN; Karahuseyinoglu S; Ince U; Taskiran C; Selek U; Yakin K; Guzel Y; Ayhan C; Alper E; Cetiner M; Balaban B; Mandel NM; Esen T; Iwase A; Urman B; Oktem O
    Hum Reprod; 2015 Dec; 30(12):2912-25. PubMed ID: 26466909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
    Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
    Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protective effect of GnRH analogues on the reproductive capacity of women with neoplasia or autoimmune disease who require chemotherapy. Final results of a phase ii clinical trial].
    Gris-Martínez JM; Trillo-Urrutia L; Gómez-Cabeza JJ; Encabo-Duró G
    Med Clin (Barc); 2016 Feb; 146(3):97-103. PubMed ID: 26194532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists.
    Danforth DR; Arbogast LK; Friedman CI
    Fertil Steril; 2005 May; 83(5):1333-8. PubMed ID: 15866565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility.
    Nguyen QN; Zerafa N; Liew SH; Morgan FH; Strasser A; Scott CL; Findlay JK; Hickey M; Hutt KJ
    Cell Death Dis; 2018 May; 9(6):618. PubMed ID: 29795269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin prevents cyclophosphamide-induced ovarian follicular loss and potentially inhibits tumour proliferation in a breast cancer xenograft mouse model.
    Tanaka Y; Amano T; Nakamura A; Yoshino F; Takebayashi A; Takahashi A; Yamanaka H; Inatomi A; Hanada T; Yoneoka Y; Tsuji S; Murakami T
    Hum Reprod; 2024 May; ():. PubMed ID: 38734930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.
    Li X; Kang X; Deng Q; Cai J; Wang Z
    Reprod Biol Endocrinol; 2013 Mar; 11():16. PubMed ID: 23452939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice.
    Sonigo C; Beau I; Grynberg M; Binart N
    FASEB J; 2019 Jan; 33(1):1278-1287. PubMed ID: 30113879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyto-protective effects of LH on ovarian reserve and female fertility during exposure to gonadotoxic alkylating agents in an adult mouse model.
    Del Castillo LM; Buigues A; Rossi V; Soriano MJ; Martinez J; De Felici M; Lamsira HK; Di Rella F; Klinger FG; Pellicer A; Herraiz S
    Hum Reprod; 2021 Aug; 36(9):2514-2528. PubMed ID: 34333622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy.
    Kano M; Sosulski AE; Zhang L; Saatcioglu HD; Wang D; Nagykery N; Sabatini ME; Gao G; Donahoe PK; Pépin D
    Proc Natl Acad Sci U S A; 2017 Feb; 114(9):E1688-E1697. PubMed ID: 28137855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: biochemical and in situ detection of deoxyribonucleic acid fragmentation in granulosa cells.
    Billig H; Furuta I; Hsueh AJ
    Endocrinology; 1994 Jan; 134(1):245-52. PubMed ID: 8275940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GnRH antagonist reduces chemotherapy-induced ovarian damage in rats by suppressing the apoptosis.
    Huang YH; Zhao XJ; Zhang QH; Xin XY
    Gynecol Oncol; 2009 Feb; 112(2):409-14. PubMed ID: 19038435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian damage from chemotherapy and current approaches to its protection.
    Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
    Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
    Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility.
    Kalich-Philosoph L; Roness H; Carmely A; Fishel-Bartal M; Ligumsky H; Paglin S; Wolf I; Kanety H; Sredni B; Meirow D
    Sci Transl Med; 2013 May; 5(185):185ra62. PubMed ID: 23677591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological administration of recombinant human AMH rescues ovarian reserve and preserves fertility in a mouse model of chemotherapy, without interfering with anti-tumoural effects.
    Roness H; Spector I; Leichtmann-Bardoogo Y; Savino AM; Dereh-Haim S; Meirow D
    J Assist Reprod Genet; 2019 Sep; 36(9):1793-1803. PubMed ID: 31250176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.